Explore the BNTX stock forecast for 2025, 2030, 2035, 2040, 2045, 2050, and 2060. Find out if BioNTech SE (BNTX) stock will rise, why it might be falling, and whether BioNTech is a good buy or sell. Get insights on long-term BNTX price predictions.
Table of Contents
Read: STRO Stock Forecast 2025, 2030, 2040 Price Target and Prediction
BioNTech SE American Depositary Share (BNTX) Company Outlook
BioNTech (NASDAQ: BNTX), a German pharmaceutical company known for its COVID-19 vaccine developed in partnership with Pfizer, has experienced significant market activity. The Covid partnership has been extremely lucrative for BioNTech, known for its work on cancer and rare disease treatments. During the pandemic, BNTX stock soared nearly 250% on the Nasdaq, raising its market capitalization to over $25 billion.
Despite a 30% drop this year, bringing the stock to $160 per share, BioNTech SE stock is still up more than 1,000% over the past five years. As sales of the Pfizer-BioNTech COVID-19 vaccine begin to slow, the companies continue their collaboration, focusing on a new influenza vaccine utilizing mRNA technology, which many industry experts view as the future of medicine.
Read: VERI Stock Forecast 2025, 2030, 2040 Veritone Analyst Estimate, Price Target
Company Profile
| Company | BioNTech SE – ADR |
|---|---|
| Sector | Health Technology |
| Industry | Biotechnology |
| CEO | Ugur Sahin (Founded – 2008) |
| Headquarters | Mainz |
| Employees (FY) | 3.08K |
| Website | biontech.de |
BioNTech SE (BNTX) Fundamental Analysis
| Previous Close | $92.07 |
| Open | $92.00 |
| Day’s Range | $91.80 – $102.64 |
| 52 Week Range | $85.21 – $125.83 |
| Volume | 3,603,128 |
| Avg. Volume | 646,779 |
| Market Cap (intraday) | $24.653B |
| PE Ratio (TTM) | 200.59 |
| EPS (TTM) | $0.51 |
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | Jun 2, 2022 |
| 1y Target Est | $115.98 |
Related: CRBG stock price prediction 2024, 2025, 2030, 2040, 2050, 2060 Growth
BioNTech SE American Depositary Share (BNTX)Historical Chart by Trading View
Long-term BioNTech SE (BNTX) Stock Price Forecast for 2025, 2030, 2035, 2040, 2045, 2050, and 2060
According to the latest long-term forecast, BioNTech SE stock (BNTX) price will hit $114 by the middle of 2024 and then $150 by the end of 2025. BioNTech SE will rise to $200 within the year 2029, $240 in 2030, $410 by 2035, $500 by 2040, $650 in 2045, $780 in 2050, and $1000 in 2060.
| Year | Predicted Price | Change (%) |
|---|---|---|
| 2025 | $175 | 71.07% |
| 2029 | $200 | 95.52% |
| 2030 | $240 | 134.61% |
| 2035 | $410 | 300.98% |
| 2040 | $500 | 388.75% |
| 2045 | $650 | 535.46% |
| 2050 | $1,049.18 | 662.11% |
| 2060 | $1,500 | 1380.37% |
Read More: VFS Stock Forecast 2025, 2030, 2040 Price Target and Prediction | KO Stock Forecast 2025, 2030, 2040 Price Target and Prediction
BioNTech SE – BNTX Stock Forecast 2024
According to our current BNTX stock forecast, we expect to see the value of BioNTech SE shares rise by 10.57% and reach $ 113.78 per share by May 28, 2024.
BioNTech SE – BNTX Stock Forecast 2025
The BioNTech SE (BNTX) stock price forecast for 2025 is currently $175, assuming that BioNTech SE shares will continue growing at the average yearly rate as they did in the past decade. This would represent a 71.07% increase in the BNTX stock price.
BioNTech SE – BNTX Stock Forecast 2029
BioNTech SE stock (BNTX) stock is projected to stick at $175 and mid-year be $189 closing at $200 per share by 2029 which is a whopping 95.52% increase from its current value.
BioNTech SE – BNTX Stock Forecast 2030
BioNTech SE stock (BNTX) will achieve an average target price of $205 per share in 2030 with a high forecast of $240, and a low forecast of $185 from its growth over the past decade. This is a whopping 134.61% increase from the current price.
BioNTech SE – BNTX Stock Forecast 2035
BioNTech SE (BNTX) is anticipated to reach an average price target of $352.33 in 2035 and in this period BioNTech SE price will rise from a low forecast to a high forecast between $387 to $410 per share. This is a whopping 300.98% increase from the current price.
BioNTech SE – BNTX Stock Forecast 2040
BioNTech SE stock (BNTX) is expected to reach a record high of $500 with an average price of $440 in 2040, and a low forecast of $400. If we assume BNTX stock will grow 388.75% from its current price.
BioNTech SE (BNTX) Stock Forecast 2045
According to our estimated forecast, BioNTech SE stock (BNTX) is expected to skyrocket to an average price of $611.71 in 2045 with a low of $590 and a high of $650. This is a whopping 535.46% increase from the last closing price of $101.20.
BioNTech SE – BNTX Stock Forecast 2050
If we assume that the BioNTech SE stock price followed the S&P 500’s historical 10.5% yearly rate of return until 2050, the BNTX stock would be priced at $1,049.18, or 12x higher than the current price.
BioNTech SE – BNTX Stock Forecast 2060
According to our current BioNTech SE (BNTX) stock forecast, the value of BioNTech (BNTX) shares will rise by 1380.37% and reach $1500 per share by 2060.
Conclusion: Why is BioNTech stock falling?
BNTX stock is dropping because analysts have reduced their estimates for how much the company will earn per share. This change caused the stock to fall by over 9%, with shares trading at $87.87, a decrease of 5.2% from before. Moreover, BioNTech SE’s fourth-quarter revenue of 3.819 billion euros was below expectations, adding to the stock’s decline.
What is the BNTX stock prediction for 2025?
Our BioNTech SE stock prediction for 2025 states that BNTX stock will reach a price of $175. This prediction derives from the stock’s average growth over the past 10 years.
What is the BNTX stock prediction for 2030?
Our BioNTech SE stock prediction for 2030 states that BNTX stock will reach a price of $240. This prediction derives from the stock’s average growth over the past 10 years.
Is BNTX a good stock to buy or Sell?
The consensus among 8 Wall Street analysts’ average price target indicates that BioNTech SE offers an 11% upside potential. The consensus rating of Moderate Buy is derived from 15 buy ratings, 17 hold ratings, and 11 sell ratings.
Does BioNTech SE pay dividends?
BioNTech SE (BNTX) does not pay a Dividend yield TTM.
How high will Biontech SE rise in 2024?
Based on analyst’s forecast 12-month price targets for BioNTech SE (BNTX) in the last 3 months. The average price target is $105.58 with a high estimate of $121 and a low estimate of $95 by the end of 2024.
Disclaimer: This information is based on historical data and analysis provided in the query. It should not be taken as financial advice. Please conduct your own research or consult a financial advisor before making any investment decisions.
Ashish Dwivedi is the founder and chief editor of MoneyMystica, a top resource for finance, insurance, and share market insights. Driven by a passion for empowering individuals to make informed financial decisions, Ashish uses his extensive knowledge and practical experience to offer clear and actionable advice.
